Similarly, in the laboratory we've been
studying cell replacement therapy.
Not exact matches
The new approach builds on information gleaned from developmental
studies of embryonic stem
cells (see story # 16) and one day may be used to create healthy
replacements for harmed or diseased tissue.
However, the
study led by Pyle found that the current methods are inefficient; they produce immature
cells that are not appropriate for modeling Duchenne in the laboratory or creating a
cell replacement therapy for the disease.
While some seek to use iPSCs as
replacements for
cells compromised by disease, the new Mount Sinai
study sought to determine if they could serve as an accurate model of genetic disease «in a dish.»
It also supports our belief that in the future, one might be able to use this approach for
replacement of
cells lost or malfunctioning due to other more common diseases of the retina,» said lead
study author
cell biologist Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University - Purdue University Indianapolis.
The authors note that the formation of each different organ bud type may require some fine tuning to optimize tissue self - organization, and further addition of neural
cell types may be necessary, but this research may soon provide exciting model systems for the
study of basic biology and pathology as well as providing appropriate
replacement tissues for the treatment of many patients with no other viable options.
(required) Advanced
Cell Culture: 3D, Fluid Flow and Co-cultureIn Vitro Models for the
Study of Neurological DiseasesStem
Cells: Developing Off the Shelf TherapeuticsCreating More Realistic Gut ModelsIn Vitro Models for Animal
Replacement
San Diego, California, October 6, 2014 — ViaCyte, Inc., a privately - held regenerative medicine company developing a stem
cell - derived islet replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as foll
cell - derived islet
replacement therapy for the treatment of diabetes, called VC - 01 ™, will give two presentations at the annual Stem
Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological Studies, as foll
Cell Meeting on the Mesa Conference, being held at the Estancia La Jolla Hotel & Spa and The Salk Institute for Biological
Studies, as follows:
One of the striking differences in outcome between our
studies and work on oligodendrocyte and oligodendrocyte - precursor
replacement lies in the finding that differentiation of precursor
cells into a specific astrocyte subtype prior to transplantation provides a much greater level of benefit than transplantation of the precursor
cells themselves.
The new iPS
cells generated using novel methods may represent biomedically - and clinically - ideal
cells, providing potential platforms for
studying human disease mechanisms and achieving the long - term goal of personalized
cell -
replacement therapy.
We have focused on the less -
studied replacement of astrocytes, the major support
cell in the central nervous system, by generating astrocytes from embryonic human glial precursor
cells using two different astrocyte differentiation inducing factors.
Understanding how heart muscle
cells, or cardiomyocytes, change in space improves efforts for
studying disease, screening drugs and conducting
cell replacement therapy for future space missions.
Silicon nanoparticles such as those in RM 8027 are being
studied as alternative semiconductor materials for next - generation photovoltaic solar
cells and solid - state lighting, and as a
replacement for carbon in the cathodes of lithium batteries.
Therefore, Hormone
Replacement Therapy (HRT) medications do not fit into hormone
cell receptors like BHRT medications; this mis - fit in molecular structure of HRT appears to have created some of the health problems associated with HRT Hormone Therapy which has been discussed in the media over the past few years (the Women's Health Initiative
Study (WHI) was released in July 2002 indicating health risks associated with synthetic HRT use).